Yazar "Erdemoglu, AK" seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Bilateral carpal tunnel syndrome associated to familial Mediterranean fever(Elsevier Science Bv, 2005) Bademci, G; Erdemoglu, AK; Evliyaoglu, C; Atasoy, P; Keskil, SA unique case of bilateral severe carpal tunnel syndrome due to familial Mediterranean fever is reported. The syndrome was diagnosed by clinical examination and electrophysiological studies. Bilateral transverse carpal ligaments were released and the biopsy specimens revealed systemic type A amyloidosis. Up to our knowledge, the co-existence of bilateral carpal tunnel syndrome and familial Mediterranean fever has not been reported previously in the literature. (c) 2004 Elsevier B.V. All rights reserved.Öğe Familial cerebellar ataxia and hypogonadism associated with sensorimotor axonal polyneuropathy(Elsevier Science Bv, 2000) Erdemoglu, AK; Akbostanci, MC; Selcuki, DIn this article, we report two siblings who have familial cerebellar ataxia and hypogonadism associated with sensorimotor axonal polyneuropathy documented by light microscopy. This combination has not been reported previously in the literature. Cerebellar ataxia and hypogonadism is reviewed according to the clinical and laboratory features of the reported cases in the literature. (C) 2000 Published by Elsevier Science B.V.Öğe Long-term efficacy and safety of Botulinum toxin type A in refractory chronic daily headache(Blackwell Publishing Ltd, 2003) Erdemoglu, AK; Varlibas, A…Öğe Valproic acid in prophylaxis of refractory migraine(Wiley, 2000) Erdemoglu, AK; Ozbakir, SObjective - The efficacy and safety of valproic acid were assessed as a prophylactic agent in migraine patients who previously derived no significant benefit from conventional prophylactic medications for migraine. Patients and methods - One hundred and twenty patients aged 23-58 years with the diagnosis of migraine without aura. Response to therapy was determined by using a headache calendar detailing the frequency and severity of attacks. Reduction of 50% or greater in the frequency or severity of headache was considered as improvement. Results - Improvement was observed in headache frequency within 67% of patients. Headache severity had been improved in 60% of patients. The mean average dosage of valproic acid was 1250 mg daily. Most of the side effects are mild and tolerable. Conclusion - These results suggest that valproic acid is effective and safe in the treatment of refractory migraine headache.
